EVT Evotec SE

DGAP-News: MUBADALA INVESTMENT COMPANY AND NOVO HOLDINGS A/S INVEST € 250 M IN EVOTEC SE

DGAP-News: MUBADALA INVESTMENT COMPANY AND NOVO HOLDINGS A/S INVEST € 250 M IN EVOTEC SE
EN
12/10/2020

Underlying

EVTEvotec SE

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Evotec SE

Jean-François Granjon ... (+3)
  • Jean-François Granjon
  • Louis Boujard
  • CFA
AUTN AUTONEUM HOLDING AG
EVT EVOTEC SE
PHA PHARMAGEST INTERACTIVE SA
ALDEL DELFINGEN INDUSTRY SA
OERL OC OERLIKON CORPORATION AG
VRAP VRANKEN-POMMERY MONOPOLE SA
NOEJ NORMA GROUP SE
POS PORR AG
ADN1 ADESSO AG
ALBFR SIDETRADE SA
SMHN SUESS MICROTEC AG
CSM CORBION NV
WPL WIRTUALNA POLSKA HOLDING SA
DMP DERMAPHARM HOLDING SE
ATRY ATRYS HEALTH
S30 SOLUTIONS 30 SE
KTA KNAUS TABBERT
LHYFE LHYFE S.A.
CO CASINO GUICHARD-PERRACHON
03/31/26 March 31, 2026 1 EN
Jean-François Granjon ... (+3)
  • Jean-François Granjon
  • Louis Boujard
  • CFA
AUTN AUTONEUM HOLDING AG
EVT EVOTEC SE
PHA PHARMAGEST INTERACTIVE SA
ALDEL DELFINGEN INDUSTRY SA
OERL OC OERLIKON CORPORATION AG
VRAP VRANKEN-POMMERY MONOPOLE SA
VETO VETOQUINOL SA
NOEJ NORMA GROUP SE
POS PORR AG
ADN1 ADESSO AG
ALBFR SIDETRADE SA
SMHN SUESS MICROTEC AG
CSM CORBION NV
WPL WIRTUALNA POLSKA HOLDING SA
DMP DERMAPHARM HOLDING SE
ATRY ATRYS HEALTH
S30 SOLUTIONS 30 SE
KTA KNAUS TABBERT
LHYFE LHYFE S.A.
CO CASINO GUICHARD-PERRACHON
03/31/26 March 31, 2026 1 FR
Oliver Metzger ... (+2)
  • Oliver Metzger
  • Stephan Wulf
03/31/26 March 31, 2026 1 EN
Thomas J. Schiessle
  • Thomas J. Schiessle
EUR 350.00
EVT EVOTEC SE

FY 25-Guidance Met – Weak Demand Forces Stricter Strategy Adjustment –...

According to KPIs, the FY 25 guidance was achieved with a Q4 final sprint – including extraordinary income from the SANDOZ deal– with €788m (-1.3% YoY) or €41m (adj. EBITDA margin: -0.7%) (details: 08.04.26). The persistently weak demand in the early drug discovery (D&PD) market could not be fully offset by the well-performing business of Just-Evotec Biologics (JEB). Evotec is struggling with undercapacity utilization. The business model must be adjusted more consistently. With clear cost contro...

03/11/26 March 11, 2026 4 EN
Oliver Metzger
  • Oliver Metzger
WCH WACKER CHEMIE AG
RNO RENAULT SA
BFIT BASIC-FIT NV
EVT EVOTEC SE
MMK MAYR-MELNHOF KARTON AG
ASY ASSYSTEM SA
GXI GERRESHEIMER AG
PIG HAULOTTE GROUP SA
BOSS HUGO BOSS AG
QDT QUADIENT SA
ELIS ELIS SA
TINC TINC COMM. VA
DUFN DUFRY AG
GALE GALENICA AG
CAN CANAL+
03/11/26 March 11, 2026 1 FR

ResearchPool Subscriptions

Get the most out of your insights

Get in touch